No Photo Available

Last Update

2001-06-14T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Colin Scott?

Dr. Colin N. Scott

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Vice President, Clinical Affairs

Emisphere Technologies , Inc.

Vice President, Clinical and Regulatory Affairs

Cytomed Inc.

Director, Medical Affairs

ASTA Medica AG

Director of Medical Affairs

Muro/ASTA Medica , Inc.

Muro/ASTA Medica , Inc. Division

Education

M.D.

medical degree

Glasgow University

Web References (6 Total References)


PharmaLive

www.medadnews.com [cached]

In addition , Emisphere also announced the appointment of Colin N. Scott , M.D. , to the position of Vice President , Clinical Affairs.

Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere , and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations , and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing , executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica , Inc. , a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG , headquartered in Frankfurt , Germany , where he held the position of Director , Medical Affairs.Previously , Dr. Scott was Vice President , Clinical and Regulatory Affairs at CytoMed , Inc..Dr. Scott received his medical degree from Glasgow University , Scotland.


Emisphere Technologies, Inc. - Emisphere Receives Patent Covering Oral Parathyroid Hormone Composition With Lilly

ir.emisphere.com [cached]

In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.

Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology. Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs. Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc. Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year. His clinical affairs expertise will also help to establish a long-term clinical development strategy for our earlier-stage product candidates. We look forward to Dr. Scott's participation in creating the clinical infrastructure necessary to capture the potential of Emisphere's product pipeline."


Smartmoney.com: News Search: Emisphere Gets Oral Parathyroid Hormone Composition Patent

www.smartmoneymag.com [cached]

Biopharmaceutical company Emisphere also named Colin N. Scott vice president of clinical affairs.Scott was director of medical affairs for Muro/ASTA Medica Inc. , a unit of ASTA Medica AG's Rx-Healthcare Division.

Company Web site : http : //www.emisphere.com
-Eamon Beltran ; Dow Jones Newswires ; 201-938-5400
( This story was originally published by Dow Jones Newswires ).


Emisphere Biosciences - Investor Relations - Investor Relations News Release

phx.corporate-ir.net [cached]

In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.

Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs.Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc.Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year.His clinical affairs expertise will also help to establish a long-term clinical development strategy for our earlier-stage product candidates.We look forward to Dr. Scott's participation in creating the clinical infrastructure necessary to capture the potential of Emisphere's product pipeline."


Emisphere Technologies, Inc. Investor Relations

www.corporate-ir.net [cached]

In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.

Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs.Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc.Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year.

Similar Profiles

Other People with this Name

Other people with the name Scott

Karen Scott
First 5 San Bernardino

Linda Scott
University of Illinois

Mitchell Scott
Chadwick Switchboards Pty Ltd

Lee Scott
Shulmans LLP

Morgan Scott
Fishermen Labs

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory